Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Elevance Health (ELV)
NYSE:ELV
Holding ELV?
Track your performance easily
ELV Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$362.21 - $567.26
Previous Close$365.96
Volume3.45M
Average Volume (3M)1.94M
Market Cap
$85.00B
Enterprise Value$87.56B
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$2.46B
Price to Earnings (P/E)13.4
Beta0.27
Next Earnings
Jan 22, 2025EPS Estimate
$3.98Last Dividend Ex-Date
Dec 05, 2024Dividend Yield1.74%
Share Statistics
EPS (TTM)27.43
Shares Outstanding231,922,815
10 Day Avg. Volume2,367,969
30 Day Avg. Volume1,944,729
Standard Deviation0.08
R-Squared0.31
Alpha-0.00046
Financial Highlights & Ratios
Price to Book (P/B)1.94
Price to Sales (P/S)0.49
Price to Cash Flow (P/CF)7.90
P/FCF Ratio7.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.50
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$508.38Price Target Upside38.92% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering15
Elevance Health News
Bulls Say, Bears Say
Bulls Say
Earnings PerformanceCarelon is identified as an important EPS driver with significant growth in the third quarter.
Financial PerformanceCarelonRx reported revenue growth of 7.3% year over year and an EBIT increase of 29.8%.
ValuationThe stock is currently trading at only 11.9x MSe '25 EPS of $35.17 vs. its 13.8x 10-Yr NTM historical avg. (vs. 12.5x current MCO peer group avg).
Bears Say
EarningsELV reported Q3 results that missed on EPS by 13% and also lowered guidance for FY24.
Medicaid MarginsMedicaid margins driven to near 0% due to pressures from redeterminations, expected to persist throughout 2025.
Membership DeclineTotal membership decreased by -3.3% in the year-over-year comparison for Q3.
---
Ownership Overview
0.12% Insiders
26.21% Mutual Funds
24.01% Other Institutional Investors
28.45% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Ability to SellRisks related to the company’s ability to sell goods and services
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ELV FAQ
What was Elevance Health’s price range in the past 12 months?
Elevance Health lowest stock price was $362.21 and its highest was $567.26 in the past 12 months.
What is Elevance Health’s market cap?
Currently, no data Available
When is Elevance Health’s upcoming earnings report date?
Elevance Health’s upcoming earnings report date is Jan 22, 2025 which is in 31 days.
How were Elevance Health’s earnings last quarter?
Elevance Health released its earnings results on Oct 17, 2024. The company reported $8.37 earnings per share for the quarter, missing the consensus estimate of $9.657 by -$1.287.
Is Elevance Health overvalued?
According to Wall Street analysts Elevance Health’s price is currently Undervalued.
Does Elevance Health pay dividends?
Elevance Health pays a Quarterly dividend of $1.63 which represents an annual dividend yield of 1.74%. See more information on Elevance Health dividends here
What is Elevance Health’s EPS estimate?
Elevance Health’s EPS estimate is $3.98.
How many shares outstanding does Elevance Health have?
Elevance Health has 231,922,820 shares outstanding.
What happened to Elevance Health’s price movement after its last earnings report?
Elevance Health reported an EPS of $8.37 in its last earnings report, missing expectations of $9.657. Following the earnings report the stock price went down -10.587%.
Which hedge fund is a major shareholder of Elevance Health?
Among the largest hedge funds holding Elevance Health’s share is First Eagle Investment Management LLC. It holds Elevance Health’s shares valued at 1B.
---
Elevance Health Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$508.38 (38.92% Upside)
$508.38 (38.92% Upside)
Blogger Sentiment
Bullish
ELV Sentiment 94%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 357.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $3.2M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.2%
Last 30 Days ▲ 0.8%
Last 30 Days ▲ 0.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-19.23%
12-Months-Change
Fundamentals
Return on Equity
15.62%
Trailing 12-Months
Asset Growth
5.48%
Trailing 12-Months
Company Description
Elevance Health
Indiana-based Anthem, Inc. was formed in 2004 after the merger of WellPoint Health Networks Inc. and Anthem, Inc. The company is one of the leading health insurance names, and provides medical benefits through a range of integrated healthcare plans and related services, along with a wide range of specialty products such as life and disability insurance benefits, dental, vision, behavioral health benefit services, as well as long-term care insurance and flexible spending accounts.
---
ELV Company Deck
---
ELV Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong performance in Elevance Health's commercial and Medicare Advantage segments, as well as significant growth in Carelon services. However, these positives were overshadowed by challenges in the Medicaid business, which led to a reduced earnings outlook and increased expense ratios. The strategic positioning in Medicare and expansion in commercial markets are promising, but the immediate financial outlook is impacted by Medicaid-related issues.Read More>---
ELV Stock 12 Month Forecast
Average Price Target
$508.38
▲(38.92% Upside)
Technical Analysis
Best Analysts Covering ELV
1 Year
---